Literature DB >> 7311

Histamine (H2) receptor-adenylate cyclase system in pig skin (epidermis).

K Iizuka Hadachi, K M Halprin, V Levine.   

Abstract

Histamine activated adenylate cyclase in pig skin (epidermal) slices, resulting in the accumulation of cyclic AMP. This effect was highly potentiated by the addition of cyclic AMP-phosphodiesterase inhibitors (theophylline, papaverine). A specific H2 receptor inhibitor (metiamide) inhibited the effect of histamine completely, while other antihistamines (diphenhydramine, acetophenazine, perphenazine, fluphenazine, promethazine) inhibited the effect of histamine to various lesser degrees. It has been shown that both epinephrine and prostaglandin E stimulate epidermal adenylate cyclase. Our data using specific blocking agents indicate that histamine, epinephrine and prostaglandin E2 act independently on the epidermal adenylate cyclase system.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 7311     DOI: 10.1016/0304-4165(76)90356-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Glucocorticoid-induced alteration of beta-adrenergic adenylate cyclase response of epidermis.

Authors:  A Ohkawara; H Iizuka
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

Review 2.  Rational use of antihistamines in allergic dermatological conditions.

Authors:  C Advenier; C Queille-Roussel
Journal:  Drugs       Date:  1989-10       Impact factor: 9.546

3.  Receptor-linked adenylate cyclase in the membranes of cultured human epidermal keratinocytes.

Authors:  M T Cavey; D Cavey; B Shroot; U Reichert; J Gazith
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

4.  Adenylate cyclase system of human trichilemmoma cell line.

Authors:  M Tsutsui; H Iizuka; A Ohkawara; K Adachi; T Kanzaki
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

5.  Histaminergic mediation of the response of rat skin to topical fluorides.

Authors:  E J Essman; W B Essman; E Valderrama
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.